MoneyWorks4Me

Dr Reddys Laboratories informs about press release

21 Mar 2026 Evaluate
Dr Reddys Laboratories has informed that it enclosed a Press Release ‘Dr. Reddy’s Laboratories announces launch of India’s first DCGI-approved Semaglutide injection ‘Obeda’ for Type 2 Diabetes’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..